Equity research analysts covering LifeMD, Inc. (NASDAQ: LFMD) maintain a consensus outlook pointing toward substantial long-term growth potential. Wall Street twelve-month price targets average roughly $7.57 to $8.80 per share, with higher estimates reaching up to $10.00. These optimistic forecasts are anchored by projected expansions in digital telehealth adoption, scaling subscriber bases within virtual primary care, and increasing revenues from specialized treatment verticals like GLP-1 weight management programs, though short-term market volatility remains a factor.